Nasdaq Technology

If you have been looking for Mid Cap Value funds, a place to start could be T. Rowe Price Mid-Cap Value Fund (TRMCX). TRMCX possesses a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on nine forecasting factors like size, cost, and past performance.

On the lookout for an Index fund? Starting with ProFunds UltraNASDAQ-100 Fund Investor (UOPIX) is one possibility. UOPIX bears a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on nine forecasting factors like size, cost, and past performance.

There are plenty of choices in the Small Cap Blend category, but where should you start your research? Well, one fund that might be worth investigating is Conestoga Small Cap Investors (CCASX). CCASX possesses a Zacks Mutual Fund Rank of 2 (Buy), which is based on nine forecasti

Maybe you're a seasoned investor and have a good track record with stock-picking. And you may have a robust retirement portfolio - perhaps including some Zacks Top Retirement stock selections such as:

Strange but true: seniors fear death less than running out of money in retirement.

Here's a revealing data point: older Americans are scared more of outliving wealth than of death itself.

Designed to provide broad exposure to the Consumer Discretionary - Broad segment of the equity market, the Fidelity MSCI Consumer Discretionary Index ETF (FDIS) is a passively managed exchange traded fund launched on 10/21/2013.

Designed to provide broad exposure to the World ETFs category of the market, the iShares MSCI ACWI Low Carbon Target ETF (CRBN) is a smart beta exchange traded fund launched on 12/08/2014.

Designed to provide broad exposure to the Large Cap Blend segment of the US equity market, the Franklin LibertyQ U.S. Equity ETF (FLQL) is a passively managed exchange traded fund launched on 04/26/2017.

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

Stocks gained more on Monday than it lost all of last week, as good news for a potential coronavirus vaccine sent the Dow higher by more than 900 points. Biotech company Moderna (MRNA) announced positive phase 1 results for its coronavirus vaccine candidate. Shares of the com

The coronavirus outbreak has had a sector-wide impact. However, the U.S. tech sector has been more resilient compared with other sectors during the coronavirus-hit earnings season.A solid data-center market, the growing adoption of cloud-based applications as well as the tech-su

Though the earnings season has reached its tail end, the main chunk of releases from the Retail-Wholesale sector is yet to come. This time the season has been quite different for retailers. The space has been hit hard by the coronavirus-induced stay-at-home orders, social distan

There are plenty of choices in the Muni - Bonds category, but where should you start your research? Well, one fund that may not be worth investigating is BlackRock Strategic Municipals Opportunities A (MEMTX). MEMTX possesses a Zacks Mutual Fund Rank of 5 (Strong Sell), which is

All three major U.S. indexes jumped Monday after Moderna announced it has seen positive results from early human tests of its coronavirus vaccine. On top of that, economies around the world are slowly starting to reopen, and Federal Reserve Chairman Jerome Powell’s 60 Minutes

On Monday, shares of biotech Moderna Inc. MRNA soared over 26% in midday trading, and closed up nearly 20% to $80 a share.

Even though FAANG and most of the big cap stocks have already reported first quarter earnings, this week is among the most important of the entire earnings season because of the retailers.

The Clorox Company CLX, is engaged in the production, marketing and sale of consumer products in the U.S. and international markets. Clorox’s shares have risen and outpaced the industry in the past three months. The stock received a boost from the robust third-quarter fiscal 2

Technology stocks were climbing in late Monday trading, with the SPDR Technology Select Sector ETF advancing 2.6% while the Philadelphia Semiconductor Index was rising 4.9%.